PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFecal microbiota
Fecal microbiota
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1037 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544—212815155108
Clostridium infectionsD003015EFO_1000874A05.211321323485
Ulcerative colitisD003093EFO_0000729K512129823483
ColitisD003092EFO_0003872K52.92328512875
Communicable diseasesD003141——614814772
SyndromeD013577——610513252
UlcerD014456MPATH_579—1522511751
Irritable bowel syndromeD043183EFO_0000555K58211623451
DiarrheaD003967—R19.7512421332
Clostridioides difficileD016360NCBITaxon_1496—61121724
Show 16 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fecal microbiota transplantationD000069467——14206—3463
Inflammatory bowel diseasesD015212EFO_0003767—9113—2847
Crohn diseaseD003424EFO_0000384K5010112—2544
Intestinal diseasesD007410—K63.911131—1837
MicrobiotaD064307——241—2530
RecurrenceD012008——2137—524
Graft vs host diseaseD006086—D89.81732—1022
Liver cirrhosisD008103EFO_0001422K74.0654—1021
FibrosisD005355——555—920
Diabetes mellitusD003920EFO_0000400E08-E13—42—1318
Show 29 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.935——2733
Healthy volunteers/patients———31——2528
Gastrointestinal microbiomeD000069196———2——2527
DysbiosisD064806——65——1826
Colorectal neoplasmsD015179———2——1517
Autism spectrum disorderD000067877—F84.046——817
MelanomaD008545——37——615
NeoplasmsD009369—C80—1——1314
Type 1 diabetes mellitusD003922EFO_0001359E10—2——1214
Brain diseasesD001927—G93.4065——614
Show 103 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Anorexia nervosaD000856EFO_0004215F50.02———68
AnorexiaD000855—R63.02———57
Liver failureD017093—K72.91———56
Alzheimer diseaseD000544EFO_0000249F031———56
HypersensitivityD006967EFO_0003785T78.401———56
HypertensionD006973EFO_0000537I102———46
Premature birthD047928EFO_0003917O601———45
MalnutritionD044342EFO_0008572E40-E461———45
ColicD003085—R10.831———34
AdenocarcinomaD000230——1———34
Show 36 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic renal insufficiencyD051436—N18————77
Rectal neoplasmsD012004——————66
Pancreatic neoplasmsD010190EFO_0003860C25————66
Necrotizing enterocolitisD020345EFO_0003928K55.3————55
SarcopeniaD055948EFO_1000653M62.84————44
End stage liver diseaseD058625EFO_1001311K72.1————44
Hepatic insufficiencyD048550——————44
Nutrition disordersD009748EFO_0001069—————44
DiseaseD004194EFO_0000408R69————44
Vancomycin-resistant enterococciD065507——————44
Show 297 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
49 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use